Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,193 stories, page 508 of 704

Advanced search

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

FDA Schedules Psychedelics Hearing, Amid New Push for Medical Approval

FilterOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical M&A activity gains momentum in Brazil

KearneyOriginal source

🌍Jul 16discoverynews.google.comTier 3 · Aggregated media

Real-world study sheds new light on safety of approved ALS drug

ALS News TodayOriginal source

🌍Jul 16Industryeledon.comTier 1 · Company source

Tegoprubart Sustains Increased eGFR Longterm Compared to Tacrolimus

Eledon PharmaceuticalsOriginal source

🌍Jul 16Industryeledon.comTier 1 · Company source

All 12 Tegoprubart Recipients Off External Insulin Following Islet Implant in Pilot Study

Eledon PharmaceuticalsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Cannara Biotech Reports Q3 2026 Results: Full Earnings Call Transcript

BenzingaOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA finalizes guidance on psychedelic drug clinical trial design and safety considerations

AllSciOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Braveheart, Attovia join next wave of biotech IPOs

BioPharma DiveOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

CervoMed Reports Positive Clinical, Biomarker and MRI Data for Neflamapimod at AAIC 2026

t.coOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Q&A: How Pharma 3PL Is Evolving Beyond the Pallet

Pharmaceutical CommerceOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

ADHD medicines prescriptions rose again in 2025

The Pharmaceutical JournalOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Johnson Fistel, PLLP Investigates Claims on Behalf of

GlobeNewswireOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

AstraZeneca licenses novel oral EGFR inhibitor for $1.5bn

European Pharmaceutical ReviewOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Veradermics reports positive Phase 2 hair loss trial results

grafa.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Stoppering Machines Market Growth Outlook to 2035: Automation and Biologics Fuel Demand - News and Statistics

IndexBoxOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD

Dermatology TimesOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Celcuity’s breast cancer drug approved, its first

STATOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Pitt signs deal with biotech firm to study mitochondria in space and long Covid

WPXIOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.

PR NewswireOriginal source

🇯🇵Jul 15Researchriken.jpTier 2 · Direct publisher

Statement on the passing of Susumu Tonegawa, Former Director of the Brain Science Institute

RIKENOriginal source

🇺🇸Jul 15universitynews.mit.eduTier 2 · Direct publisher

Ketogenic diets may increase cancer risk in the small intestine

MIT Biology NewsOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Big Pharma-backed AdvanCell, flush with $315M series D, ready to put radiotherapy pedal to the metal

Fierce BiotechOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

DOJ’s Bulk Sensitive Personal Data Rule: A Cross-Border Compliance Imperative for the Life Sciences Industry

Morgan LewisOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Katalyze AI Raises $10.5M to Build the Agentic Operating System for Pharmaceutical Companies

AI InsiderOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

J&J axes eye disease gene therapy after key phase 2b readout

Fierce BiotechOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits

Investor's Business DailyOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Treating a Rare Form of Obesity Caused by Brain Injury

Northwestern UniversityOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Kelun scores sac-TMT win in first-line NSCLC population missing from Merck’s massive phase 3 program

Fierce PharmaOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe Effect: FDA Turns To AI For Instant Food Adulteration, Fake Med Complaints

NDTV ProfitOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part One

PharmTech.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

China targets pharmaceutical supply chains in coordinated fraud inspections

Insurance BusinessOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Merck to present HIV treatment trial data at AIDS conference By Investing.com

Investing.com IndiaOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

Review Body on Doctors' and Dentists' Remuneration remit letter: 2027 to 2028

Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Healt...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

NHS Pay Review Body remit letter: 2027 to 2028

Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Healt...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

Senior Salaries Review Body remit letter: 2027 to 2028

Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Healt...

UK Department of Health and Social CareOriginal source

🇩🇪Jul 15Researchuk-essen.deTier 2 · Direct publisher

Drei Herztransplantationen in fünf Tagen – dreimal Beating Heart-Technik

Universitätsklinikum EssenOriginal source

🇺🇰Jul 15Industrygsk.comTier 1 · Company source

GSK completes acquisition of Nuvalent, Inc.

GSK NewsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Smarter data, faster decisions: How biotech funding pressures are reshaping clinical development

Clinical Trials ArenaOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Explained: 7 Major FDA Crackdowns In Pune Under Tukaram Mundhe, From Blood Banks To Counterfeit Cetaphil Skin

Free Press JournalOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Akeso Opens U.S. Phase II Trial for PD-1/CTLA-4 Bispecific

t.coOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

American Airlines Cargo builds pharma corridor connecting Europe and the US

Air Cargo NewsOriginal source

🌍Jul 15discoverynews.google.comTier 2 · Trade media

AAIC26: The role of biomarkers in primary care and early diagnostics

Pharmaceutical TechnologyOriginal source

🇺🇸Jul 15Industrybambusatx.comTier 1 · Company source

Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board

Bambusa TherapeuticsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA Activity Round Up – July 2026

PharmTech.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA drug approval affects healthcare around the world, but political shortcuts could hurt the agency’s international reputation

themercury.comOriginal source

🇺🇸Jul 15Devicesviz.aiTier 1 · Company source

Viz.ai to Support the MINUTE Trial, a Landmark Multicenter Study Evaluating the SCUBA Technique for the Treatment of Intracerebral Hemorrhage

Viz.aiOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Cellular Intelligence Expands Leadership Team with Seasoned AI and Biotech Industry Executives

Yahoo FinanceOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech reports Phase III success for sac-TMT combination in NSCLC

BioSpectrum AsiaOriginal source

🌍Jul 15Industrysignanthealth.comTier 1 · Company source

Even the most complex RTSM builds no longer set the pace for trial timelines

Signant HealthOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next

marketscreener.comOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Atrium Therapeutics Launches Phase 1/2 Trial for ATR 1072

t.coOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA drug approval affects healthcare around the world, but political shortcuts could hurt the agency’s international reputation

The ConversationOriginal source

🇺🇰Jul 15Regulatorygov.ukTier 1 · Regulatory source

Surveillance of bloodstream infections in intensive care units, England: 2025

Annual report and data tables showing how often bloodstream infections occur in critical care in Eng...

UK Health Security AgencyOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Lakewood-Amedex Biotherapeutics Announces Preclinical Safety Data Supporting Clinical Dose Selection for Upcoming Phase 2a Trial of Nu-3 Gel

Yahoo Finance SingaporeOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

BRIEF-Cannara Biotech Q3 EPS CAD 0.05

TradingViewOriginal source

🇨🇦Jul 15Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Presource ®Kits containing Teleflex Pilling® Wecksorb Neurosponge

Cardinal Health was recently informed of a medical device recall from Teleflex concerning the Pillin...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 15Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Leoni Plus

An electronic component may overheat internally.

Health Canada Recalls and Safety AlertsOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

aTyr's 44-patient analysis shows 123.8 mL lung-function benefit

Stock TitanOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Cannara Biotech (LOVE) Investor presentation Summary

QuartrOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)

Yahoo Finance SingaporeOriginal source